Trial intelligence / Profile preview

Phase 2a of Trivalent Seasonal Influenza VLP Vaccine in Healthy Adults

NCT00903552Phase 2Completed

Sponsor
Novavax
Start
May 2009
Primary completion
Oct 2009
Modality
Nanoparticles, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza VLP vaccine in seasonal influenza, sponsored by Novavax. Started May 2009; status: completed.

02

Drugs

influenza VLP vaccine
03

Conditions

seasonal influenza

Beyond the preview

Go deeper on NCT00903552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00903552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call